VBI Vaccines
VBIV
#10530
Rank
C$2.57 M
Marketcap
C$0.08989
Share price
0.00%
Change (1 day)
-89.64%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): C-$13.57

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is C-$13.96. In 2022 the company made an earnings per share (EPS) of C-$18.17 a decrease over its 2021 EPS that were of C-$11.15.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$13.57
2022C-$18.1762.96%
2021C-$11.1528.57%
2020C-$8.67-54.35%
2019C-$19.00-52.58%
2018C-$40.0610.23%
2017C-$36.3414.29%
2016C-$31.80-62.8%
2015C-$85.4990.68%
2014C-$44.83-7.95%
2013C-$48.71-57.97%
2012C-$115.90-78%
2011C-$526.913151.47%
2010C-$16.2123.87%
2009C-$13.08-18.48%
2008C-$16.0512.08%
2007C-$14.32-49.47%
2006C-$28.34
2005N/A-100%
2004C-$12.6011.94%
2003C-$11.25-81.89%
2002C-$62.15196.44%
2001C-$20.9684.33%
2000C-$11.37-65.37%
1999C-$32.84-29.45%
1998C-$46.5529.61%
1997C-$35.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
C-$1.31-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$5.96-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C-$5.05-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA